Home LiteratureArticle Details
PMID: 2139011 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Oxygen-dependent up-regulation of mucoid exopolysaccharide (alginate) production in Pseudomonas aeruginosa.

Infection and immunity ·Vol. 58 ·No. 5 ·1990-05-00 ·Pages 1344-9

Bayer AS, Eftekhar F, Tu J, Nast CC, Speert DP

Abstract

We previously showed substantial differences in Pseudomonas aeruginosa exopolysaccharide production in vitro at oxygen tensions reflective of the right versus left cardiac circuits in vivo (40 versus 80 mm Hg, respectively; A. S. Bayer, T. O'Brien, D. C. Norman, and C. C. Nast, J. Antimicrob. Chemother. 23:21-35, 1989). However, those studies did not specifically confirm this exopolysaccharide to be the characteristic P. aeruginosa mucoid alginate seen in patients with cystic fibrosis. With a murine monoclonal antibody prepared against P. aeruginosa alginate, strongly positive immunofluorescence (IF) staining of a nonmucoid P. aeruginosa strain (PA-96) was seen after its exposure in vitro to oxygen tensions (pO2) of approximately 80 mm Hg; the intensity of the IF staining under these conditions was similar to that observed with a phenotypically mucoid P. aeruginosa strain (C1712M) from a cystic fibrosis patient. In contrast, the same nonmucoid strain (PA-96), after exposure to pO2 of approximately 40 mm Hg, showed little IF staining for alginate. Following enzyme treatment with alginase, PA-96 cells previously exposed to the higher pO2 and exhibiting enhanced alginate production, as determined by IF staining, now showed no IF staining. Moreover, treatment of the oxygen-up-regulated PA-96 cells with alginase released amounts of unsaturated alginate breakdown products (uronic acids) quantitatively similar to those released by typically mucoid strains treated with the same enzyme. These data indicated that the P. aeruginosa exopolysaccharide in our studies was, indeed, mucoid alginate and that variations in oxygen tensions represent one of the trigger mechanisms for the up-regulation of mucoid exopolysaccharide production.

MeSH Terms
Fluorescent Antibody Technique Glycosaminoglycans/biosynthesis Glycoside Hydrolases/metabolism Oxygen/physiology Polysaccharide-Lyases Polysaccharides, Bacterial/biosynthesis Pseudomonas aeruginosa/metabolism
Chemicals
Glycosaminoglycans Polysaccharides, Bacterial mucoid exopolysaccharide (P aeruginosa) Glycoside Hydrolases Polysaccharide-Lyases poly(beta-D-mannuronate) lyase Oxygen
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Bayer A S
Department of Medicine, Harbor-UCLA Medical Center, Torrance 90509.
Eftekhar F
Tu J
Nast C C
Speert D P
References (25)
25 references, click to expand
  1. Production and characterization of the slime polysaccharide of Pseudomonas aeruginosa.
    J Bacteriol. 1973 Nov;116(2):915-24 PMID: 4200860
  2. The formation of 2-keto-3-deoxyheptonic acid in extracts of Escherichia coli B. I. Identification.
    J Biol Chem. 1959 Apr;234(4):705-9 PMID: 13654246
  3. Summary of a workshop on infections in patients with cystic fibrosis.
    J Infect Dis. 1979 Aug;140(2):252-6 PMID: 39103
  4. The penetration of antibiotics through sodium alginate and through the exopolysaccharide of a mucoid strain of Pseudomonas aeruginosa.
    Lancet. 1981 Sep 5;2(8245):502-3 PMID: 6115250
  5. Current problems in the treatment of infective endocarditis due to Pseudomonas aeruginosa.
    Rev Infect Dis. 1983 Mar-Apr;5(2):314-21 PMID: 6405476
  6. Role of Pseudomonas aeruginosa mucoid exopolysaccharide in adherence to tracheal cells.
    Infect Immun. 1985 Jan;47(1):1-4 PMID: 3155514
  7. The purification and chemical characterisation of the alginate present in extracellular material produced by mucoid strains of Pseudomonas aeruginosa.
    Carbohydr Res. 1984 Dec 15;135(1):147-54 PMID: 6441642
  8. Influence of nutrient media on the characteristics of the exopolysaccharide produced by three mucoid Pseudomonas aeruginosa strains.
    Microbios. 1984;41(163):49-63 PMID: 6441885
  9. Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material.
    Antimicrob Agents Chemother. 1985 Apr;27(4):619-24 PMID: 3923925
  10. Polysaccharide surface antigens expressed by nonmucoid isolates of Pseudomonas aeruginosa from cystic fibrosis patients.
    J Clin Microbiol. 1986 Aug;24(2):189-96 PMID: 2943759
  11. Aeration selects for mucoid phenotype of Pseudomonas aeruginosa.
    J Clin Microbiol. 1986 Dec;24(6):986-90 PMID: 3097070
  12. Construction and characterization of Pseudomonas aeruginosa algB mutants: role of algB in high-level production of alginate.
    J Bacteriol. 1987 Apr;169(4):1593-602 PMID: 3031015
  13. Alginate production by clinical nonmucoid Pseudomonas aeruginosa strains.
    J Clin Microbiol. 1987 Apr;25(4):656-9 PMID: 3106409
  14. Hypochlorite scavenging by Pseudomonas aeruginosa alginate.
    Infect Immun. 1987 Aug;55(8):1813-8 PMID: 3038752
  15. Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis.
    N Engl J Med. 1987 Sep 24;317(13):793-8 PMID: 2957591
  16. Enzymatic modification of glycocalyx in the treatment of experimental endocarditis due to viridans streptococci.
    J Infect Dis. 1987 Nov;156(5):736-40 PMID: 3655403
  17. Mucoid Pseudomonas aeruginosa resists nonopsonic phagocytosis by human neutrophils and macrophages.
    Pediatr Res. 1987 Oct;22(4):429-31 PMID: 2891100
  18. Cloning of genes from mucoid Pseudomonas aeruginosa which control spontaneous conversion to the alginate production phenotype.
    J Bacteriol. 1988 Apr;170(4):1452-60 PMID: 2965141
  19. Alginase treatment of mucoid Pseudomonas aeruginosa enhances phagocytosis by human monocyte-derived macrophages.
    Infect Immun. 1988 Nov;56(11):2788-93 PMID: 3139564
  20. Oxygen-dependent differences in exopolysaccharide production and aminoglycoside inhibitory-bactericidal interactions with Pseudomonas aeruginosa--implications for endocarditis.
    J Antimicrob Chemother. 1989 Jan;23(1):21-35 PMID: 2501267
  21. Pathogenic effects of monocytopenia, granulocytopenia and dexamethasone on the course of experimental Pseudomonas aeruginosa endocarditis in rabbits.
    Chemotherapy. 1989;35(4):278-88 PMID: 2504546
  22. Interaction of biofilm bacteria with antibiotics in a novel in vitro chemostat system.
    Antimicrob Agents Chemother. 1989 Oct;33(10):1824-6 PMID: 2511804
  23. Conversion of Pseudomonas aeruginosa to the phenotype characteristic of strains from patients with cystic fibrosis.
    J Clin Microbiol. 1990 Feb;28(2):188-94 PMID: 2107198
  24. Protein measurement with the Folin phenol reagent.
    J Biol Chem. 1951 Nov;193(1):265-75 PMID: 14907713
  25. Single or combination therapy of staphylococcal endocarditis in intravenous drug abusers.
    Ann Intern Med. 1979 May;90(5):789-91 PMID: 434682
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1990-05-00
Pages
1344-9
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC258630
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com